Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: SINO BIOLOGICAL US INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-21 to 2024-01-19
Current total value of award: $65500
Description: ANTIVIRAL DRUG DEVELOPMENT OF HYBRIDOMA CELL LINES AND ANTIBODY FOR VIRAL ANTIGENS